Manufacturing “quality by design”
FDA's Pharmaceutical Science Advisory Committee/Manufacturing Subcommittee will discuss "quality by design" approaches and how they contrast to approaches that test-in quality during a Sept. 17 meeting. On Sept. 18 the subcommittee will discuss and define principles by which risk management is integrated into decision making. The meeting will begin at 8:30 a.m. at 5630 Fishers Lane, Rockville, Md. both days...
You may also be interested in...
A lack of regulatory harmonization for dietary supplements in Asia is a big challenge facing companies operating in the region, according to experts from the Asia Regulatory Professionals Association. The ARPA is looking to start a conversation on the issue which the association hopes will lead to regulatory change.
The Chinese Society of Clinical Oncology (CSCO) annual meeting, against the background of the global pandemic, has one clear message that local researchers and players are pressing ahead to take a leadership role in cutting-edge cancer research globally.
Company is confident that data readout from pivotal trial could be ready before the end of 2020.